Tazobactam and Piperacillin API: By Type, By Application, and Region Forecast 2019-2030

Tazobactam and Piperacillin API By Type (18,14), By Application (Injection, Others), and Region Forecast 2019-2030

Tazobactam and piperacillin API Market size was valued at US$ 431.7 million in 2023 and poised to grow at a CAGR of 2.1% from 2024-2030. The market value is changed due to the dynamic pricing of the tazobactam. The price of tazobactam API is US$ 877.4 per kg. However, the demand for tazobactam and piperacillin was increasing over the forecast years due to the drug shortages in Europe and North America region. Qilu is the major supplier of tazobactam and piperacillin in the global market.

However, the fire accident that happened in 2016, has created a significant impact on the availability of the API in the market due to which the company has lost a few of its customers where the competitor has taken an opportunity to enter into their customer’s supply chain for tazobactam API. Qilu Tianhe holds the highest market share of around 49.8% in tazobactam API production followed by Fuxiang with 25.3%. The market is a duopoly market dominated by Qilu and Fuxiang. Tazobactam is used mostly in combination with piperacillin. However, there are a few other molecules where the tazobactam combination used that includes Ceftazidime, Cefoperazone, and Ceftriaxone.In June 2022, the Piperacillin & Tazobactam API market in Europe showcased an increase on the back of improving demand with limited regional supply. 

Tazobactam and Piperacillin API Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

2.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Tazobactam and Piperacillin API Market Dynamics

Bacterial diseases continue to be the leading cause of morbidity and mortality worldwide. Inadequate funding, subpar microbiology services, a lack of technical experts, and a need for epidemiological data to guide better preventive and treatment strategies all contribute to the rise in the burden of bacterial infections. Infectious diseases are prevalent in different parts of the world, regardless of developing or developed countries, and are heavily influenced by vulnerable populations, social inequality, economic imbalance, limited access to healthcare, and other factors. A high incidence of antimicrobial resistance (AMR) also coexists with this rise in the burden of bacterial illnesses.The global burden of infectious diseases is high, particularly in low- and lower-middle-income countries (LMICs). In contrast, non-communicable diseases are responsible for most deaths in upper-middle and high-income countries.

However, developed countries are still vulnerable to outbreaks of bacterial infections due to increased international travel. In 2019, approximately 7 million people died of infectious diseases, accounting for nearly 12% of all deaths globally. Furthermore, it has been estimated that 700,000 deaths occur each year globally due to drug-resistant organisms. If preventive and control measures are not taken, this number could rise to 10 million by 2050, with an economic loss of $100 trillion.Piperacillin/tazobactam is an effective combination antibiotic against a broad range of bacteria, including those that produce beta-lactamases. It is used to treat various infections, including lower respiratory tract infections, intra-abdominal infections, urinary tract infections, gynecological infections, skin and soft tissue infections, and fever in patients with neutropenia. In severe cases, piperacillin/tazobactam may be combined with an aminoglycoside antibiotic. Moreover, the demand for piperacillin/tazobactam API is increasing due to the increase in prevalence of infectious diseases.

Tazobactam and Piperacillin API Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 431.7 million

Market CAGR

2.1%

By Type

  • 1:8
  • 1:4

By Application

  • Injection
  • Others

By Region

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Key Features of the Report

  • The tazobactam and piperacillin api market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The global tazobactam and piperacillin api market size was valued at US$ 431.7 million in 2023 and poised to grow at a CAGR of 2.1% from 2024-2030.

The key market players in the market are Fresenius Kabi, Qilu Pharmaceutical Co., Ltd., SUANFARMA, Otsuka Chemical Co.,Ltd., Jiangxi Fushine Pharmaceutical Co., Ltd., Aurobindo Pharma, Zhejiang Benfor Biotech Co.,Ltd, and Reyoung Pharmaceutical Co., Ltd

Asia pacific is the fastest growing market in the report.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Tazobactam and Piperacillin API Market Introduction 
2.1.Global Tazobactam and Piperacillin API Market  - Taxonomy
2.2.Global Tazobactam and Piperacillin API Market  - Definitions
2.2.1.Type
2.2.2.Application
2.2.3.Region
3.Global Tazobactam and Piperacillin API Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Tazobactam and Piperacillin API Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Tazobactam and Piperacillin API Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. 0.0472222222222222
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. 0.0444444444444444
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Tazobactam and Piperacillin API Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Injection
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Others
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Tazobactam and Piperacillin API Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Tazobactam and Piperacillin API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.0.0472222222222222
8.1.2.0.0444444444444444
8.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Injection
8.2.2.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Tazobactam and Piperacillin API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.0.0472222222222222
9.1.2.0.0444444444444444
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Injection
9.2.2.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Tazobactam and Piperacillin API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.0.0472222222222222
10.1.2.0.0444444444444444
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Injection
10.2.2.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Tazobactam and Piperacillin API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.0.0472222222222222
11.1.2.0.0444444444444444
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Injection
11.2.2.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Tazobactam and Piperacillin API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.0.0472222222222222
12.1.2.0.0444444444444444
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Injection
12.2.2.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Fresenius Kabi
13.2.2.Qilu Pharmaceutical Co., Ltd.
13.2.3.SUANFARMA
13.2.4.Otsuka Chemical Co.,Ltd.
13.2.5.Jiangxi Fushine Pharmaceutical Co., Ltd.
13.2.6.Aurobindo Pharma
13.2.7.Zhejiang Benfor Biotech Co.,Ltd
13.2.8.Reyoung Pharmaceutical Co., Ltd
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Fresenius Kabi
  • Qilu Pharmaceutical Co., Ltd.
  • SUANFARMA
  • Otsuka Chemical Co.,Ltd.
  • Jiangxi Fushine Pharmaceutical Co., Ltd.
  • Aurobindo Pharma
  • Zhejiang Benfor Biotech Co.,Ltd
  • Reyoung Pharmaceutical Co., Ltd

Related Industry Reports